A second-generation blood substitute (perfluorodichlorooctane emulsion) does not activate complement during an ex vivo circulation model of bypass. [electronic resource]
Producer: 19981027Description: 397-401 p. digitalISSN:- 1053-0770
- Adolescent
- Adult
- Aged
- Anticoagulants -- therapeutic use
- Blood Substitutes -- administration & dosage
- Cardiopulmonary Bypass -- instrumentation
- Complement Activation -- drug effects
- Complement C3a -- analysis
- Complement Factor B -- analysis
- Crystalloid Solutions
- Emulsions
- Female
- Filtration -- instrumentation
- Fluorocarbons -- administration & dosage
- Heparin -- therapeutic use
- Humans
- Hydrocarbons, Chlorinated -- administration & dosage
- Hydrocarbons, Fluorinated -- administration & dosage
- Isotonic Solutions
- Male
- Middle Aged
- Oxygenators, Membrane
- Plasma Substitutes -- therapeutic use
- Prospective Studies
- Single-Blind Method
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.